Drug Type Bispecific antibody |
Synonyms CRPE7A2 |
Target |
Mechanism E7 inhibitors(Protein E7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HPV16 Infection | Discovery | CN | 25 Jul 2022 | |
Uterine Cervical Cancer | Discovery | CN | 25 Jul 2022 |